A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexia

Protocol code: &nbsp;70033093STR3001
EudraCT code: &nbsp;No aplica
Principal investigator: &nbsp; Molina Cateriano, Carlos
Research group: &nbsp; Recerca en ictus
Service: &nbsp;Neurologia
Phase: &nbsp;Fase III
Recruiting: &nbsp;Open
Status: &nbsp;Iniciat

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack/Estudio de fase III, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para demostrar la eficacia y la seguridad de milvexian, un inhibidor oral del factor XIa, para la prevención de accidentes cerebrovasculares después de un accidente cerebrovascular isquémico agudo o un accidente isquémico transitorio de alto riesgo.

Contact

I have read and accept the data protection policy *.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.